Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment
AUTOR(ES)
Bathe, Oliver F
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183847Documentos Relacionados
- CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination
- Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
- Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
- Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells
- Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.